Helius Medical Technologies is trading at $2.50, up 5.13% from the October 8 close of $2.38; no fresh company-specific catalyst was identified for October 9.
- The latest indexed company release found was the September 30 offering announcement.
- The Nasdaq Composite was up 0.81% pre-market, which may be supportive but does not establish the cause of the move.
- Volume and other activity-level data were not provided.